机译:仅肝硬化和纤维化-4更好地预测肝脏事件与Antrs Co13 Hepavih Cohort中的人类免疫缺陷病毒和丙型肝炎病毒共感染患者的血小板比指数相比。
Bordeaux Univ INSERM Bordeaux Populat Hlth Res Ctr ISPED Team MORPH3EUS UMR 1219 Bordeaux;
Paris Descartes Univ Cochin Hosp Paris Publ Hosp Pasteur Inst Liver Unit INSERM U1223 Paris;
Univ Hosp Ctr Lyon Croix Rousse Hosp Infect &
Trop Dis Unit Lyon France;
St Antonius Hosp Paris Publ Hosp Infect &
Trop Dis Unit Paris France;
Reg Hlth Observ Prov Alpes Cote dAzur INSERM IRD U912 SE4S UMR S912 ORS PACA Marseille France;
Tenon Hosp Paris Publ Hosp Paris Infect &
Trop Dis Unit Paris France;
Univ Hosp Paris Sud Bicetre Hosp Paris Publ Hosp Infect &
Trop Dis Unit Paris France;
Bordeaux Univ Hosp Ctr Pellegrin Hosp Infect &
Trop Dis Unit Bordeaux France;
Perpignan Hosp Ctr Infect &
Trop Dis Unit Perpignan France;
Toulouse Univ Hosp Ctr Purpan Hosp Internal Med Toulouse France;
Dijon Univ Hosp Ctr Dept Infectiol Dijon France;
Avicenne Hosp Paris Publ Hosp Infect &
Trop Dis Unit Bobigny France;
Hop La Pitie Salpetriere Paris Publ Hosp Dept Internal Med &
Clin Immunol Paris France;
UniveBordeaux Univ Bordeaux France;
St Louis Hosp Paris Publ Hosp Infect &
Trop Dis Unit Paris France;
Bichat Claude Bernard Hosp AP HP Infect &
Trop Dis Unit Paris France;
Nice Univ Hosp Ctr Infectiol Ctr Archet 1 Hosp Nice France;
Nice Sophia Antipolis Univ Nice France;
Joseph Ducuing Hosp Med Unit Toulouse France;
Toulouse Univ Hosp Ctr Purpan Hosp Gastroenterol &
Hepatol Unit Toulouse France;
Bordeaux Univ INSERM Bordeaux Populat Hlth Res Ctr ISPED Team MORPH3EUS UMR 1219 Bordeaux;
Cochin Hosp Paris Publ Hosp Infect &
Trop Dis Unit Paris France;
Bordeaux Univ INSERM Bordeaux Populat Hlth Res Ctr ISPED Team MORPH3EUS UMR 1219 Bordeaux;
Hop St Andre Virol Bordeaux France;
APHP Pitie Salpetriere Malad Infect &
Trop Paris France;
CHU Purpan Toulouse France;
APHP Bichat Claude Bernard Med Interne Paris France;
APHP Necker Med Interne Paris France;
CHU Pellegrin Malad Infect &
Trop Bordeaux France;
Hop Haut Leveque Med Interne &
Malad Infect Bordeaux France;
CHRU Med Interne Malad Infect &
Immunol Clin Strasbourg France;
CH Perpignan Dept Infectiol Perpignan France;
APHM St Marguerite Med Interne Marseille France;
APHP Antoine Beclere Med Interne Clamart France;
CHU Henri Mondor Med Interne Creteil France;
CHU Dijon Malad Infect &
Trop Dijon France;
Hop Croix Rousse Malad Infect &
Trop Lyon France;
CHU Robert Debre Malad Infect &
Trop Reims France;
APHP Bichat Claude Bernard Trait Union Paris France;
human immunodeficiency virus; hepatitis C virus co-infection; liver-related events; noninvasive markers; prediction;
机译:仅肝硬化和纤维化-4更好地预测肝脏事件与Antrs Co13 Hepavih Cohort中的人类免疫缺陷病毒和丙型肝炎病毒共感染患者的血小板比指数相比。
机译:优化的临界值提高了天冬氨酸转氨酶与血小板比率指数的性能,可预测人免疫缺陷病毒/丙型肝炎病毒共感染中的明显肝纤维化。
机译:天冬氨酸转氨酶与血小板比率指数和Fibrosis-4指数诊断成人慢性乙型肝炎病毒感染患者肝纤维化的诊断准确性比较:系统评价和荟萃分析
机译:天冬氨酸氨基转移酶/丙氨酸转移酶比(AST / ALT比率)与慢性肝炎患者肝纤维化阶段的相关性
机译:在丙型肝炎病毒(免疫缺陷)合并感染的一组患者中,人类免疫缺陷病毒的发病机理。
机译:FIB-4天冬氨酸转氨酶与血小板的比率指数和肝硬度测定对丙型肝炎病毒持续正常丙氨酸转氨酶患者的诊断价值
机译:血清纤维化标记板FiB-4指数和天冬氨酸氨基转移酶(AST) - 血小板比指数(APRI)相当于在预测肝炎病毒感染的1731名患者队列的肝纤维化时单独的AST